Department of Defence Tender by Dg Armed Forces Medical Service (bc8f59de)

AMLODIPINE 5 MG TAB,ATORVASTATIN 10 MG TAB,BRIVARACETAM 50MG TAB,CAPD CASSETTES,CHOLECALCIFEROL INJ

Goods
Qty:5.5L

Tender Timeline

Tender Issue
May 28, 2025 at 1:07 PM

Tender Title: MEDICINE DEMAND ECHS RE 06
Tender Reference Number: bc8f59de
Issuing Authority/Department: Ministry of Defence, Department of Defence

Scope of Work and Objectives

The primary objective of this tender is to fulfill the demand for various medicines and medical supplies required by the Ex-Servicemen Contributory Health Scheme (ECHS). This includes the procurement of a wide range of pharmaceutical products, including but not limited to Amlodipine 5 MG Tablets, Atorvastatin 10 MG Tablets, Brivaracetam 50MG Tablets, and other essential medications. The total quantity for procurement amounts to 545,305 units, ensuring adequate supply for the healthcare needs of beneficiaries.

Eligibility Criteria

To participate in this tender, bidders must meet the following eligibility requirements:

  • Registered entities in accordance with relevant drug manufacturing laws.
  • Possession of valid licenses for the distribution of pharmaceuticals.
  • Compliance with the Quality Standards set forth by regulatory bodies.
  • Financial stability is preferred, demonstrating the ability to fulfill the contract terms.

Technical Requirements

Bids must conform to strict technical specifications established for each product category. Interested bidders must provide:

  • Certificates of analysis from recognized laboratories for all proposed medicines.
  • Documentation outlining testing criteria and compliance with quality regulations.
  • Comprehensive details relating to the mechanisms of manufacture and supply.

Financial Requirements

Bidders are required to present:

  • Earnest Money Deposit (EMD) details, indicating the security amount pledged to the tender process.
  • Performance Security requirements for successful bidders, which must be valid throughout the contract duration.
  • A transparent payment structure, covering terms and timelines for payment after delivery and acceptance of goods.

Document Submission Details

All proposals must be submitted electronically through the designated portal. The documents should be in the accepted formats specified in the guidelines and should align with the submission criteria outlined in the tender documentation. Ensure that all required certificates and documentation supporting compliance, financial status, and technical capabilities are included to facilitate the evaluation process.

Special Provisions

This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and start-ups by providing specific benefits and concessions. Bidders eligible as MSEs may avail themselves of extended support, enhancing their capacity to compete within this tender framework.

Evaluation Process

Bids will undergo a comprehensive evaluation process, focusing on both technical and financial criteria. Selection will prioritize compliance with all standards mandated, alongside a performance-based evaluation of pricing strategies. Transparency will be maintained throughout the evaluation procedure, ensuring equal opportunity for all bidders.

Delivery Locations

Specified delivery locations encompass multiple healthcare facilities established under the ECHS network. Detailed delivery guidelines will be provided to ensure timely and efficient distribution of supplies.

Contact Information

For inquiries regarding this tender, interested parties may contact the Ministry of Defence. Further details regarding communication protocols are available in the tender documents.


Tender BOQ Items

28 Items
1.

AMLODIPINE 5 MG TAB

Qty:274000
Unit:no
30
2.

ATORVASTATIN 10 MG TAB

Qty:214000
Unit:no
30
3.

BRIVARACETAM 50MG TAB

Qty:5400
Unit:no
30
4.

CAPD CASSETTES

Qty:360
Unit:no
30
5.

CHOLECALCIFEROL INJ

Qty:340
Unit:amp
30
6.

CLOBETASOL AND MICONOZOLE AND GENTAMYCIN OINT

Qty:1120
Unit:tube
30
7.

DESIDUSTAT 50MG TAB

Qty:4800
Unit:no
30
8.

DIGOXIN 0 POINT 25 MG TAB

Qty:3900
Unit:no
30
9.

ED BRINZOLAMIDE 1 PERCENTAGE

Qty:250
Unit:bott
30
10.

ED PREDNISOLONE 1 PERCENTAGE

Qty:15
Unit:bott
30
11.

FLUCONAZOLE 150 MG CAP OR TAB

Qty:14400
Unit:no
30
12.

FRUSEMIDE 40 MG LASIX TAB

Qty:920
Unit:no
30
13.

INH IPRATROPIUM BROMIDE 20MCG AND LEVOSALBUTAMOL 50 MCG MDI

Qty:440
Unit:no
30
14.

INJ ERYTHROPOIETIN RECOMBINANT HUMAN 2000 IU

Qty:150
Unit:pfs
30
15.

INJ TT TETANUS TOXOID 5 ML

Qty:10
Unit:vial
30
16.

LAMOTRIGINE 50 MG TAB

Qty:3200
Unit:no
30
17.

MEGESTEROL ACETATE 40MG TAB

Qty:1880
Unit:no
30
18.

METRONIDAZOLE 400 MG TAB

Qty:7200
Unit:no
30
19.

NINTEDANIB 100MG CAP

Qty:300
Unit:no
30
20.

OLANZAPINE 10 MG TAB

Qty:7100
Unit:no
30
21.

POLYETHELEN GLYCOL PLUS PROPYLENE GLYCOL SYSTANE EYE DROP

Qty:180
Unit:bott
30
22.

PROCHLOROPERAZINE 5MG TAB

Qty:3000
Unit:no
30
23.

SALMETEROL 50MCG AND FLUTICASONE PROPIONATE 250MCG SERETIDE ACCUHALER 50 AND 250

Qty:230
Unit:no
30
24.

SODIUM LACTATE RINGER LACTATE FLUID 500ML BOTT

Qty:80
Unit:bott
30
25.

TADALAFIL 10MG TAB

Qty:750
Unit:no
30
26.

TIMOLOL MALEATE EYE DROP 0 POINT 5 PERCENTAGE BOTT OF 5 ML

Qty:320
Unit:bott
30
27.

WARFARIN 1MG TAB

Qty:300
Unit:no
30
28.

PERAMPANEL 4 MG TAB

Qty:660
Unit:no
30

General Information

Item Category
AMLODIPINE 5 MG TAB , ATORVASTATIN 10 MG TAB , BRIVARACETAM 50MG TAB , CAPD CASSETTES , CHOLECALCIFEROL INJ , CLOBETASOL AND MICONOZOLE AND GENTAMYCIN OINT , DESIDUSTAT 50MG TAB , DIGOXIN 0 POINT 25 MG TAB , ED BRINZOLAMIDE 1 PERCENTAGE , ED PREDNISOLONE 1 PERCENTAGE , FLUCONAZOLE 150 MG CAP OR TAB , FRUSEMIDE 40 MG LASIX TAB , INH IPRATROPIUM BROMIDE 20MCG AND LEVOSALBUTAMOL 50 MCG MDI , INJ ERYTHROPOIETIN RECOMBINANT HUMAN 2000 IU , INJ TT TETANUS TOXOID 5 ML , LAMOTRIGINE 50 MG TAB , MEGESTEROL ACETATE 40MG TAB , METRONIDAZOLE 400 MG TAB , NINTEDANIB 100MG CAP , OLANZAPINE 10 MG TAB , POLYETHELEN GLYCOL PLUS PROPYLENE GLYCOL SYSTANE EYE DROP , PROCHLOROPERAZINE 5MG TAB , SALMETEROL 50MCG AND FLUTICASONE PROPIONATE 250MCG SERETIDE ACCUHALER 50 AND 250 , SODIUM LACTATE RINGER LACTATE FLUID 500ML BOTT , TADALAFIL 10MG TAB , TIMOLOL MALEATE EYE DROP 0 POINT 5 PERCENTAGE BOTT OF 5 ML , WARFARIN 1MG TAB , PERAMPANEL 4 MG TAB
Ministry Name
Department Name

Financial Information

Bid Offer Validity
90 (Days)
Past Performance
60 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7887188.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC)
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Morphine 15 mg, 1 ml Inj,Pethedine 50 mg, 1 ml Inj,Tramadol HCl 50 mg Cap or Tab,Clonazepam 2 mg Ta

GEM
Goods
Qty:4.5L
4 Files
Indian Army
Boq › Boql
Morphine 15 mg, 1 ml Inj , Pethedine 50 mg, 1 ml Inj , Tramadol HCl 50 mg Cap or Tab , Clonazepam 2 mg Tab , Clotrimazole mouth paint 1 percent bottle of 15 ml , Tranexamic Acid 500 mg per 5ml Inj , Antiseptic mouth wash containing Sodium fluoride and triclosan bott of 100 ml , Benzocaine 20 percent, Pectin based, oral ointment Tube of 5 gm , Adapalene 0.1 percent Tube of 15 gm , Benzoyl Peroxide 2.5 percent Tube of 20 gm , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg , Metoclopramide syrup 5mg percent 5ml bott of 30 ml , Isapgol or Ispaghula husk 3.5 gm , Loperamide 2mg Tab , Gentamicin sulphate 0.3 percent w per v gentamicin base with Hydrocortisone acetate IP 1 percent w per v eye and ear drops bott of 5 ml , Cinnarizine 25 mg Tab , Clotrimazole 1 percent w per v IP plus Lignocaine 2 percent w per v IP ear drop, bott of 10ml , Nasal Decongestant adult drops, Xylometazoline HCl 0.1 percent w per v nasal drop bottle of 10 ml , Metronidazole susp 200 mg per 5ml bott of 60 ml , Alprazolam 0.25 mg Tab , Sterile water, amp of 10 ml , Anti phlebitis cream Tube of 15 g or 20 g , Glucosamine 500 mg Tab , Antacid chewable containing dried Aluminium Hydroxide IP 250 mg, Mag Hydroxide NF 250 mg, Methyl Polysiloxane 50 mg Tab , Hepatitis B Vaccine 10 ml , Glucose saline isotonic solution in non toxic disposable plastic bott of 500ml FFS , Adjustable arm pouch sling size L or M or S , Heel Cup, Silicon or Carbon Copolymer , Cough sedative syp, each 5 ml containingChlorpheniramine maleate 2.5mg, Guaiphenesin 100mg, Noscapine 15mg, Sodium citrate 60mg in flavoured base, bott of 100 ml
May 30, 2025
June 21, 2025 at 11:00 AM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity compliant with local pharmaceutical regulations and possessing valid licenses for drug distribution. Bidders should have a demonstrated financial capacity to fulfill contract obligations and maintain compliance with quality standards specified in the tender documentation. Participation is encouraged from entities aligned with the Make in India initiative, supporting local production efforts.

Bidders must adhere to rigorous technical specifications defined for each pharmaceutical category outlined in the tender. Each product must be supported by a certificate of analysis confirming compliance with quality standards. Additionally, documentation that provides insights into production protocols and compliance with testing criteria is required to ensure that all medications meet necessary regulatory benchmarks.

The Earnest Money Deposit (EMD) serves as a financial safeguard in the bidding process, guaranteeing that bidders are serious about fulfilling the tender requirements. Participants are required to submit the EMD amount alongside their proposal. Details regarding the exact amount and submission process are detailed in the tender documentation, with a focus on ensuring that all deposits are in compliance with the regulations stated therein.

Successful bidders will receive payment based on predefined payment terms, which cover timelines and conditions under which payments are released post-delivery. Payments will be contingent upon satisfactory examination and acceptance of commodities delivered as per specifications in the tender documentation. Details regarding any performance security conditions should also be carefully reviewed.

Yes, this tender includes benefits for Micro, Small, and Medium Enterprises (MSEs) and provisions designed to support startups. These benefits may include relaxed qualification criteria, financial supports, or preferential treatment during the evaluation process. Participation from these sectors is encouraged, and specific provisions are clearly outlined in the tender guidelines, ensuring a fair and equitable opportunity to compete.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders